This article explains the 4 shifts enabling faster, lower-risk, commercially successful biologics technology transfer.
Sherry Gu
Advertisement
Sherry Gu, PhD, executive vice president, chief technology officer and chief client officer of WuXi Biologics.
Articles by Sherry Gu
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
4
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
5